pmol/L. The mean FT4(U)/FT4(D)
ratio in patients with nonthyroidal illnesses (1.97) was not significantly higher than in control subjects (1.68), making it unlikely that the increase in serum FT4 is caused by weakly protein-bound and therefore dialyzable inhibitors of thyroxin binding to carrier proteins. However, two nonthyroidally ill patients with a clearly increased
FT4(U) but a normal FT4(D) concentration might have had such inhibitors, whereas
for two other nonthyroidaily ill patients a high molar ratio of free fatty acids to albumin is a more likely explanation for increased FT4(U) and FT4(D) concentrations.
On theoretical grounds, we consider the FT4(U) concentrations analytically more nearly accurate than FT4(D) values for all patient groups studied. Figure 1 . Figure  2 shows the correlation between the FT4(U) and FT4(D) concentrations for the subjects studied.
Values measured by the ultrafiltration method were higher than by equilibrium dialysis ( 
